Clinical trial
Sequential Predictions Under Repeated Interventions: Estimating the Risk of Major Bleeding or Death With and Without Prophylactic Platelet Transfusion in Thrombocytopenic Neonates.
NCT06043050 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sequential Predictions Under Repeated Interventions: Estimating the Risk of Major Bleeding or Death With and Without Prophylactic Platelet Transfusion in Thrombocytopenic Neonates.
- Lead sponsor
- Leiden University Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 26, 2022
- Completion date
- April 30, 2024
- Enrollment
- 1,042 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
intraventricular hemorrhage, neonatal thrombocytopenia, platelet transfusion